ASTI — Aquarius Surgical Technologies Income Statement
0.000.00%
Last trade - 00:00- CA$0.28m
- CA$6.84m
- CA$0.09m
Annual income statement for Aquarius Surgical Technologies, fiscal year end - March 31st, CAD millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.583 | 0.328 | 0.204 | 0.205 | 0.091 |
| Cost of Revenue | |||||
| Gross Profit | 0.217 | 0.13 | 0.082 | 0.133 | 0.047 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 2.41 | 1.48 | 0.957 | 0.956 | 0.953 |
| Operating Profit | -1.83 | -1.15 | -0.753 | -0.751 | -0.862 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -1.81 | -0.859 | -0.723 | -0.749 | -1.17 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -1.81 | -0.859 | -0.723 | -0.758 | -1.17 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -1.81 | -0.859 | -0.723 | -0.758 | -1.17 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -1.81 | -0.859 | -0.723 | -0.758 | -1.17 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.05 | -0.037 | -0.034 | -0.027 | -0.042 |